Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial.

Autoimmune disorders result when your body’s immune system becomes overactive, causing it to attack and damage your tissues. There is a good deal of overlap between autoimmune disorders and ...